Latest Amides Stories
BOCA RATON, Fla., March 12, 2015 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for dabigatran etexilate
VANCOUVER, British Columbia and MENLO PARK, Calif., March 2, 2015 /PRNewswire/ -- DelMar Pharmaceuticals,
-- First BLA submission for an investigational reversal agent for a novel oral anticoagulant RIDGEFIELD, Conn., March 2, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Study Met Primary Endpoint of Progression-Free Survival THOUSAND OAKS, Calif.
- Farydak, an HDAC inhibitor with epigenetic activity, approved in combination for patients who received at least two prior regimens including bortezomib and IMiD1 EAST HANOVER, N.J., Feb.
Transparency Market Research added new report "Polyacrylamide Market (Non-ionic, Cationic, Anionic, and Others) for Water Treatment, Petroleum, Paper Making and Other Applications - Global
WOODCLIFF LAKE, N.J., Feb.
ReportsnReports.com adds “Global and Chinese Tolvaptan Industry, 2009-2019 Market Research Report” to its store. Dallas, TX (PRWEB) February 04, 2015
Xarelto Drug Safety Label Warns Bleeding Is A Common Adverse Reaction Of The Blood Thinner And Xarelto Bleeding Side-Effects Lawsuits Claim The Anticoagulant Does Not Have An Antidote Should Severe
- Emitting flashes of light; glittering.